These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9730197)

  • 21. Risk factors for bronchopulmonary dysplasia in very low birth weight newborns treated with mechanical ventilation in the first week of life.
    Cunha GS; Mezzacappa-Filho F; Ribeiro JD
    J Trop Pediatr; 2005 Dec; 51(6):334-40. PubMed ID: 15927945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of exogenous surfactant replacement therapy on lung function.
    Yüksel B; Greenough A
    Turk J Pediatr; 1993; 35(1):53-7. PubMed ID: 8236518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of infants weighing 500-999 grams at birth in a Singapore hospital (1990-1993).
    Ho NK; Lim SB
    Singapore Med J; 1995 Apr; 36(2):185-8. PubMed ID: 7676264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mid- and long-term outcome of extremely low birth weight (ELBW) infants: an analysis of prognostic factors.
    Valcamonico A; Accorsi P; Sanzeni C; Martelli P; La Boria P; Cavazza A; Frusca T
    J Matern Fetal Neonatal Med; 2007 Jun; 20(6):465-71. PubMed ID: 17674256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [High frequency oscillation ventilation after surfactant use in hyaline membrane disease. Outcome of ventilation parameters].
    Claris O; Lapillonne A; Madinier-Chappat N; Miguet D; Salle BL
    Cah Anesthesiol; 1994; 42(3):325-8. PubMed ID: 7812856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
    Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
    Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endotracheal continuous positive airway pressure after rescue surfactant therapy.
    Mandy GT; Moïse AA; Smith EO; Hansen TN
    J Perinatol; 1998; 18(6 Pt 1):444-8. PubMed ID: 9848758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal outcome of inborn and outborn extremely low birth weight infants: relevance of perinatal factors.
    Arad I; Braunstein R; Bar-Oz B
    Isr Med Assoc J; 2008 Jun; 10(6):457-61. PubMed ID: 18669147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions.
    Weisman L
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S33-7; discussion S37-9. PubMed ID: 12671450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Masculinizing" effect on respiratory morbidity in girls from unlike-sex preterm twins: a possible transchorionic paracrine effect.
    Shinwell ES; Reichman B; Lerner-Geva L; Boyko V; Blickstein I;
    Pediatrics; 2007 Sep; 120(3):e447-53. PubMed ID: 17766488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal transport of very low birth weight infants in Jerusalem, revisited.
    Arad I; Baras M; Bar-Oz B; Gofin R
    Isr Med Assoc J; 2006 Jul; 8(7):477-82. PubMed ID: 16889163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-10 -1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants.
    Yanamandra K; Boggs P; Loggins J; Baier RJ
    Pediatr Pulmonol; 2005 May; 39(5):426-32. PubMed ID: 15678510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pneumothorax in premature neonates with hyaline membrane disease: risk factors and consequences].
    Roeleveld-Versteegh AB; Groenendaal F
    Tijdschr Kindergeneeskd; 1992 Dec; 60(6):221-5. PubMed ID: 1488734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Very low birth weight infants--mortality and predictive risk factors.
    Chye JK; Lim CT
    Singapore Med J; 1999 Sep; 40(9):565-70. PubMed ID: 10628243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect from surfactant therapy in extremely low birth weight infants depending on the method of delivery].
    Iarŭkova N; Nikolov A; Slŭncheva B; Vakrilova L; Pramatarova T; Dimitrov A
    Akush Ginekol (Sofiia); 2007; 46(3):31-5. PubMed ID: 18018780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia.
    Parker RA; Lindstrom DP; Cotton RB
    Pediatrics; 1992 Nov; 90(5):663-8. PubMed ID: 1408535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surfactant replacement therapy for pulmonary diseases.
    Pramanik AK; Holtzman RB; Merritt TA
    Pediatr Clin North Am; 1993 Oct; 40(5):913-36. PubMed ID: 8414715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost and effectiveness of surfactant replacement therapy at Johannesburg Hospital, November 1991-December 1992.
    Davies VA; Ballot DE; Rothberg AD
    S Afr Med J; 1995 Jul; 85(7):646-9. PubMed ID: 7482081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchopulmonary dysplasia and surfactant.
    Bancalari E; del Moral T
    Biol Neonate; 2001 May; 80 Suppl 1():7-13. PubMed ID: 11359038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.